logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Hiv1

    FiltersReset Filters
    26 results

    • abacavir and lamivudine

      (Abacavir and Lamivudine)
      Laurus Labs Limited
      Usage: Abacavir and lamivudine tablets are indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection when used in combination with other antiretroviral agents.

    • apretude

      (Cabotegravir)
      ViiV Healthcare Company
      Usage: APRETUDE is indicated for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection in adults and adolescents weighing at least 35 kg who are at risk of HIV-1. A negative HIV-1 test is required before starting treatment.

    • biktarvy

      (bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate)
      Gilead Sciences, Inc.
      Usage: BIKTARVY is indicated for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 14 kg, either as a complete regimen for those with no antiretroviral treatment history or as a replacement for those who are virologically suppressed on a stable regimen without resistance issues.

    • darunavir

      (Darunavir)
      Amneal Pharmaceuticals NY LLC
      Usage: Darunavir, when combined with ritonavir and other antiretroviral agents, is indicated for the treatment of HIV-1 infection in patients aged 3 years and older.

    • dovato

      (dolutegravir sodium and lamivudine)
      ViiV Healthcare Company
      Usage: DOVATO is indicated for the treatment of HIV-1 infection in adults and adolescents (12 years and older, weighing at least 25 kg) who are either treatment-naive or virologically suppressed on a stable regimen without known resistance issues.

    • edurant

      (rilpivirine hydrochloride)
      Janssen Products, LP
      Usage: EDURANT is indicated for the treatment of HIV-1 in treatment-naïve patients aged 2 and older with specific viral loads. It is also used in combination with cabotegravir for short-term treatment in adults and adolescents who are virologically suppressed and require an oral lead-in or temporary oral therapy.

    • efavirenz

      (Efavirenz)
      Aurobindo Pharma Limited
      Usage: Efavirenz capsules, in combination with other antiretroviral agents, are indicated for treating HIV-1 infection in adults and pediatric patients aged at least 3 months and weighing a minimum of 3.5 kg.

    • efavirenz

      (Efavirenz)
      Macleods Pharmaceuticals Limited
      Usage: Efavirenz, in combination with other antiretroviral agents, is indicated for treating HIV-1 infection in adults and pediatric patients aged at least 3 months who weigh at least 3.5 kg.

    • emtricitabine

      (Emtricitabine)
      Aurobindo Pharma Limited
      Usage: Emtricitabine capsules are indicated for the treatment of HIV-1 infection, to be used in combination with other antiretroviral medications.

    • emtricitabine

      (emtricitabine)
      Cipla USA Inc.
      Usage: Emtricitabine is indicated for the treatment of HIV-1 infection, used in combination with other antiretroviral agents.